Home

tjära diet Mening rtx medication sammansmältning Farväl En trogen

Systematic review of the role of rituximab in treatment of antineutrop |  OARRR
Systematic review of the role of rituximab in treatment of antineutrop | OARRR

Differences in rituximab use between pediatric rheumatologists and  nephrologists for the treatment of refractory lupus nephritis and renal  flare in childhood-onset SLE | Pediatric Rheumatology | Full Text
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text

Outcome data of RTX treatment. | Download Table
Outcome data of RTX treatment. | Download Table

Rituximab and antimetabolite treatment of granulomatous and lymphocytic  interstitial lung disease in common variable immunodeficiency - Journal of  Allergy and Clinical Immunology
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency - Journal of Allergy and Clinical Immunology

Marvel's Guardians of the Galaxy gets RTX treatment, along with 12 other  games - Opera News
Marvel's Guardians of the Galaxy gets RTX treatment, along with 12 other games - Opera News

Indications for treatment with RTX in patients with severe and... |  Download Table
Indications for treatment with RTX in patients with severe and... | Download Table

Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract  Symptoms, Urodynamic Parameters, and Quality of Life of Patients with  Urodynamic Increased Bladder Sensation - European Urology
Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation - European Urology

Nonmedical Switch to Rituximab Biosimilar Appears Effective for RA -  Rheumatology Advisor
Nonmedical Switch to Rituximab Biosimilar Appears Effective for RA - Rheumatology Advisor

The immunological phenotype of rituximab-sensitive chronic  graft-versus-host disease: a phase II study | Haematologica
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study | Haematologica

The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine

Differences in rituximab use between pediatric rheumatologists and  nephrologists for the treatment of refractory lupus nephritis and renal  flare in childhood-onset SLE | Pediatric Rheumatology | Full Text
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text

Clinical efficacy of combined rituximab treatment in a woman with severe  Graves' ophthalmopathy
Clinical efficacy of combined rituximab treatment in a woman with severe Graves' ophthalmopathy

Frontiers | A Retrospective Analysis of Rituximab Treatment for B Cell  Depletion in Different Pediatric Indications | Pediatrics
Frontiers | A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications | Pediatrics

RTX treatment reduces bacterial burden in the infected eyes. A.... |  Download Scientific Diagram
RTX treatment reduces bacterial burden in the infected eyes. A.... | Download Scientific Diagram

JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung  Disease Associated with Autoimmune Diseases: Experience from a Single  Referral Center and Literature Review | HTML
JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review | HTML

A prospective cohort study of rituximab in the treatment of refractory  nephrotic syndrome | SpringerLink
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome | SpringerLink

E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric  myelin oligodendrocyte glycoprotein antibody-associated disorders -  ScienceDirect
E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders - ScienceDirect

JCM | Free Full-Text | Off-Label Use of Rituximab in Patients with  Different Types of Nephropathies in a Tertiary Hospital: A Retrospective  Study | HTML
JCM | Free Full-Text | Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study | HTML

How to Quit Antidepressants: Very Slowly, Doctors Say - The New York Times
How to Quit Antidepressants: Very Slowly, Doctors Say - The New York Times

Randomized controlled trial of RTX vs ivMP for the treatment of active... |  Download Scientific Diagram
Randomized controlled trial of RTX vs ivMP for the treatment of active... | Download Scientific Diagram

Treatment of MOG-IgG-associated disorder with rituximab: An international  study of 121 patients - Multiple Sclerosis and Related Disorders
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients - Multiple Sclerosis and Related Disorders

Rituximab as a rescue treatment added on mycophenolate mofetil background  therapy in progressive systemic sclerosis associated interstitial lung  disease unresponsive to conventional immunosuppression - ScienceDirect
Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression - ScienceDirect

JCM | Free Full-Text | A Follow-Up Study of a European IgG4-Related Disease  Cohort Treated with Rituximab | HTML
JCM | Free Full-Text | A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab | HTML

Effect of low-dose rituximab treatment on T- and B-cell lymphocyte  imbalance in refractory myasthenia gravis - ScienceDirect
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect

Underlying disease, immunosuppressive medication, time from last... |  Download Scientific Diagram
Underlying disease, immunosuppressive medication, time from last... | Download Scientific Diagram

Preliminary results from a phase 1b double-blind study to assess the  safety, tolerability and efficacy of intra-articular administration of  resiniferatoxin or placebo for the treatment of moderate to severe pain due  to
Preliminary results from a phase 1b double-blind study to assess the safety, tolerability and efficacy of intra-articular administration of resiniferatoxin or placebo for the treatment of moderate to severe pain due to